BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22580722)

  • 1. Effect of light exposure on metalloporphyrin-treated newborn mice.
    Schulz S; Wong RJ; Kalish FS; Zhao H; Jang KY; Vreman HJ; Stevenson DK
    Pediatr Res; 2012 Aug; 72(2):161-8. PubMed ID: 22580722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zinc deuteroporphyrin bis glycol on newborn mice after heme loading.
    He CX; Campbell CM; Zhao H; Kalish FS; Schulz S; Vreman HJ; Wong RJ; Stevenson DK
    Pediatr Res; 2011 Nov; 70(5):467-72. PubMed ID: 21785387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of zinc deuteroporphyrin IX 2,4 bis glycol inhibits heme oxygenase in neonatal rats.
    Vallier HA; Rodgers PA; Stevenson DK
    Dev Pharmacol Ther; 1991; 17(3-4):220-2. PubMed ID: 1841841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG.
    Vreman HJ; Lee OK; Stevenson DK
    Am J Med Sci; 1991 Dec; 302(6):335-41. PubMed ID: 1772116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of light on metalloporphyrin-treated newborn mice.
    Wong RJ; Schulz S; Espadas C; Vreman HJ; Rajadas J; Stevenson DK
    Acta Paediatr; 2014 May; 103(5):474-9. PubMed ID: 24417721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic effects of orally-administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice.
    Morioka I; Wong RJ; Abate A; Vreman HJ; Contag CH; Stevenson DK
    Pediatr Res; 2006 May; 59(5):667-72. PubMed ID: 16627879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations.
    Appleton SD; Chretien ML; McLaughlin BE; Vreman HJ; Stevenson DK; Brien JF; Nakatsu K; Maurice DH; Marks GS
    Drug Metab Dispos; 1999 Oct; 27(10):1214-9. PubMed ID: 10497150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1.
    Zhang W; Contag PR; Hardy J; Zhao H; Vreman HJ; Hajdena-Dawson M; Wong RJ; Stevenson DK; Contag CH
    J Mol Med (Berl); 2002 Oct; 80(10):655-64. PubMed ID: 12395150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of zinc deuteroporphyrin IX 2,4-bis-glycol by the neonatal rat small intestine in vivo.
    Vallier HA; Rodgers PA; Castillo RO; Stevenson DK
    Dev Pharmacol Ther; 1991; 17(1-2):109-15. PubMed ID: 1811916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heme oxygenase after oral vs intraperitoneal administration of chromium porphyrins.
    Vallier HA; Rodgers PA; Stevenson DK
    Life Sci; 1993; 52(10):PL79-84. PubMed ID: 8445977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endogenous carbon monoxide production induces transient retention losses in the day-old chick when trained using a single trial passive avoidance learning task.
    Cutajar MC; Edwards TM; Ng KT
    Neurobiol Learn Mem; 2005 May; 83(3):243-50. PubMed ID: 15820860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity.
    Vreman HJ; Ekstrand BC; Stevenson DK
    Pediatr Res; 1993 Feb; 33(2):195-200. PubMed ID: 8433895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
    Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
    Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloporphyrins in the management of neonatal hyperbilirubinemia.
    Stevenson DK; Wong RJ
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):164-8. PubMed ID: 20006567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin.
    Chernick RJ; Martasek P; Levere RD; Margreiter R; Abraham NG
    Hepatology; 1989 Sep; 10(3):365-9. PubMed ID: 2759552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins.
    Wong RJ; Vreman HJ; Schulz S; Kalish FS; Pierce NW; Stevenson DK
    J Perinatol; 2011 Apr; 31 Suppl 1():S35-41. PubMed ID: 21448202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of porphyrin heme oxygenase inhibitors.
    Vreman HJ; Cipkala DA; Stevenson DK
    Can J Physiol Pharmacol; 1996 Mar; 74(3):278-85. PubMed ID: 8773407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality of metalloporphyrin-treated neonatal rats after light exposure.
    Hintz SR; Vreman HJ; Stevenson DK
    Dev Pharmacol Ther; 1990; 14(3):187-92. PubMed ID: 2364856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human adult and fetal heme oxygenase by new synthetic heme analogues.
    Mitrione SM; Villalon P; Lutton JD; Levere RD; Abraham NG
    Am J Med Sci; 1988 Sep; 296(3):180-6. PubMed ID: 3177434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative photoactivity of tin and zinc porphyrin inhibitors of heme oxygenase: pronounced photolability of the zinc compounds.
    Greenbaum NL; Kappas A
    Photochem Photobiol; 1991 Aug; 54(2):183-92. PubMed ID: 1780355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.